PETER KUGEL
0607.848.520 · rovalta.com · 23/09/2026
PETER KUGEL
Overview
What does PETER KUGEL do?
PETER KUGEL is a Private limited company incorporated in 2015. Its main activity is: Legal activities. Its registered office is in Bruxelles.
1000 Bruxelles · BruxellesSee on map
Trend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||
| Gross margin | 455 k € | +137% | 192,1 k € | -57.9% | 455,8 k € | -6.3% | 486,7 k € | +104% | 238,5 k € | +6.3% | 224,4 k € | -28.7% | 314,7 k € | -9.2% | 346,6 k € |
| EBITDA | 453,5 k € | +138% | 190,6 k € | -57.9% | 452,9 k € | -2.8% | 466,2 k € | +107% | 225,6 k € | +7.5% | 209,8 k € | -33.1% | 313,8 k € | -9.3% | 345,8 k € |
| Operating result | 418,7 k € | +186% | 146,4 k € | -64.3% | 410,3 k € | -3.0% | 423,1 k € | +146% | 172,3 k € | +3.8% | 166,1 k € | -36.5% | 261,4 k € | -8.6% | 285,9 k € |
| Net result | 288,8 k € | +179% | 103,4 k € | -63.4% | 282,7 k € | -9.8% | 313,5 k € | +153% | 123,7 k € | +15.3% | 107,3 k € | -36.5% | 168,9 k € | -8.2% | 183,9 k € |
| Balance sheet | |||||||||||||||
| Equity | 906,1 k € | +46.8% | 617,3 k € | +20.1% | 513,9 k € | +122% | 231,2 k € | +1030% | 20,5 k € | -95.7% | 472,5 k € | +29.4% | 365,2 k € | +86.0% | 196,3 k € |
| Total assets | 1 M € | +36.5% | 747,8 k € | +9.6% | 682,5 k € | -20.8% | 862,2 k € | +3.8% | 830,7 k € | -3.8% | 863,7 k € | +6.6% | 809,9 k € | +19.0% | 680,6 k € |
| Cash | 507,4 k € | +29.6% | 391,6 k € | +6.1% | 369 k € | -40.7% | 622,4 k € | +84.9% | 336,7 k € | +10.9% | 303,6 k € | +9.9% | 276,4 k € | +32.7% | 208,3 k € |
| Debts | 110 k € | -15.7% | 130,6 k € | -22.5% | 168,6 k € | -73.1% | 625,5 k € | -22.5% | 806,6 k € | +108% | 387,6 k € | -12.0% | 440,6 k € | -8.4% | 480,7 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/06/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ALBA HOLDING● Active | 1038.846.046 |
ARMED CELL THERAPEUTICS● Active | 1039.592.451 |
BIOQUBE FACTORY FUND I● Active | 0747.784.678 |
| 1016.717.178 | |
Bioqube Factory Fund II Privak● Active | 1016.385.497 |
Domein van Vorselaar● Active | 0423.793.790 |
EDWIN VERMULST● Active | 0862.424.030 |
Fibrocor Therapeutics Europe● Active | 1025.566.152 |
MERISANT EUROPE● Active | 0471.239.064 |
Orgues De Facto● Active | 0763.798.685 |
| 0400.488.749 | |
Société des Habitations à Bon Marché● Liquidation | 0403.363.117 |
Stoffels IMC● Active | 0780.918.294 |
VIPOWA● Active | 0886.120.437 |
VVGB 2016● Active | 0654.806.418 |
VVGB Advocaten fv● Active | 0525.904.504 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/12/2025 | 12/12/2024 | 18/01/2024 | 21/12/2022 | 17/01/2022 | 05/01/2021 |
| General meeting | 08/12/2025 | 09/12/2024 | 19/12/2023 | 12/12/2022 | 17/01/2022 | 28/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
11 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 08/12/2025 | 16/12/2025 | Dutch | |
| Abridged model | 30/06/2024 | 09/12/2024 | 12/12/2024 | Dutch | |
| Abridged model | 30/06/2023 | 19/12/2023 | 18/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 12/12/2022 | 21/12/2022 | Dutch | |
| Micro model | 30/06/2021 | 17/01/2022 | 17/01/2022 | Dutch | |
| Micro model | 30/06/2020 | 28/12/2020 | 05/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 19/12/2019 | 06/02/2020 | Dutch | |
| Micro model | 30/06/2018 | 04/12/2018 | 07/12/2018 | Dutch | |
| Abridged modelCorrection | 30/06/2017 | 11/06/2018 | 11/06/2018 | Dutch | |
| Abridged model | 30/06/2017 | 12/01/2018 | 25/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 06/01/2017 | 12/01/2017 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/06/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025288,8 k €↑
- 2024Annual accounts 2024103,4 k €↓
- 2023Annual accounts 2023282,7 k €↓
- 2022Annual accounts 2022313,5 k €↑
- 2019Annual accounts 2019123,7 k €↑
- 2018Annual accounts 2018107,3 k €↓
- 2017Annual accounts 2017168,9 k €↓
- 2016Annual accounts 2016183,9 k €
- 19/03/2015IncorporationPrivate limited company